Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer

  • López de Maturana, Evangelina
  • Rodríguez, Juan Antonio
  • Lao, Oscar
  • Molina-Montes, Esther
  • Martín-Antoniano, Isabel Adoración
  • Molero Richard, Francesc Xavier
  • Balsells Valls, Joaquin
  • Alonso, Lola
Estructura genòmica 3D; Predisposició genètica; Risc de càncer de pàncrees, Estructura genómica 3D; Predisposición genética; Riesgo de cáncer de páncreas, 3D genomic structure; Genetic susceptibility; Pancreatic cancer risk, Background Pancreatic cancer (PC) is a complex disease in which both non-genetic and genetic factors interplay. To date, 40 GWAS hits have been associated with PC risk in individuals of European descent, explaining 4.1% of the phenotypic variance. Methods We complemented a new conventional PC GWAS (1D) with genome spatial autocorrelation analysis (2D) permitting to prioritize low frequency variants not detected by GWAS. These were further expanded via Hi-C map (3D) interactions to gain additional insight into the inherited basis of PC. In silico functional analysis of public genomic information allowed prioritization of potentially relevant candidate variants. Results We identified several new variants located in genes for which there is experimental evidence of their implication in the biology and function of pancreatic acinar cells. Among them is a novel independent variant in NR5A2 (rs3790840) with a meta-analysis p value = 5.91E−06 in 1D approach and a Local Moran’s Index (LMI) = 7.76 in 2D approach. We also identified a multi-hit region in CASC8—a lncRNA associated with pancreatic carcinogenesis—with a lowest p value = 6.91E−05. Importantly, two new PC loci were identified both by 2D and 3D approaches: SIAH3 (LMI = 18.24), CTRB2/BCAR1 (LMI = 6.03), in addition to a chromatin interacting region in XBP1—a major regulator of the ER stress and unfolded protein responses in acinar cells—identified by 3D; all of them with a strong in silico functional support. Conclusions This multi-step strategy, combined with an in-depth in silico functional analysis, offers a comprehensive approach to advance the study of PC genetic susceptibility and could be applied to other diseases., The work was partially supported by Fondo de Investigaciones Sanitarias (FIS), Instituto de Salud Carlos III, Spain (#PI061614, #PI11/01542, #PI0902102, #PI12/01635, #PI12/00815, #PI15/01573, #PI18/01347); Red Temática de Investigación Cooperativa en Cáncer, Spain (#RD12/0036/0034, #RD12/0036/0050, #RD12/0036/0073); Spanish Ministerio de Ciencia, Innovación y Universidades (#BFU2017-85926-P); Fundación Científica de la AECC, Spain; European Cooperation in Science and Technology - COST Action #BM1204: EUPancreas. EU-6FP Integrated Project (#018771-MOLDIAG-PACA), EU-FP7-HEALTH (#259737-CANCERALIA, #256974-EPC-TM-Net), EU-FP7-ERC (#609989); Associazione Italiana Ricerca sul Cancro (#12182); Cancer Focus Northern Ireland and Department for Employment and Learning; and ALF (#SLL20130022), Sweden; Pancreatic Cancer Collective (PCC): Lustgarten Foundation & Stand-Up to Cancer (SU2C #6179); Intramural Research Program of the Division of Cancer Epidemiology and Genetics, National Cancer Institute, USA; PANC4 GWAS RO1CA154823; NCI, US-NIH (#HHSN261200800001E).
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Endothelial cell activation on 3D-matrices derived from PDGF-BB-stimulated fibroblasts is mediated by Snail1

  • Herrera, Alberto
  • Herrera, Mercedes
  • Guerra-Perez, Natalia
  • Galindo-Pumariño, Cristina
  • Larriba, María Jesús
  • García-Barberán, Vanesa
  • Gil, Beatriz
  • Giménez-Moyano, Sara
  • Ferreiro-Monteagudo, Reyes
  • Veguillas, Pilar
  • Candia, Antonio
  • Peña, Raúl|||0000-0002-1650-9720
  • Pinto, Jesús
  • García-Bermejo, Mª Laura
  • Muñoz, Alberto|||0000-0003-3890-4251
  • Garcia de Herreros, Antonio|||0000-0001-5270-0808
  • Bonilla, Félix
  • Carrato, Alfredo|||0000-0001-7749-8140
  • Peña, Cristina
Carcinomas, such as colon cancer, initiate their invasion by rescuing the innate plasticity of both epithelial cells and stromal cells. Although Snail is a transcriptional factor involved in the Epithelial-Mesenchymal Transition, in recent years, many studies have also identified the major role of Snail in the activation of Cancer-Associated Fibroblast (CAF) cells and the remodeling of the extracellular matrix. In CAFs, Platelet-derived growth factor (PDGF) receptor signaling is a major functional determinant. High expression of both SNAI1 and PDGF receptors is associated with poor prognosis in cancer patients, but the mechanism(s) that underlie these connections are not understood. In this study, we demonstrate that PDGF-activated fibroblasts stimulate extracellular matrix (ECM) fiber remodeling and deposition. Furthermore, we describe how SNAI1, through the FAK pathway, is a necessary factor for ECM fiber organization. The parallel-oriented fibers are used by endothelial cells as "tracks", facilitating their activation and the creation of tubular structures mimicking in vivo capillary formation. Accordingly, Snail1 expression in fibroblasts was required for the co-adjuvant effect of these cells on matrix remodeling and neoangiogenesis when co-xenografted in nude mice. Finally, in tumor samples from colorectal cancer patients a direct association between stromal SNAI1 expression and the endothelial marker CD34 was observed. In summary, our results advance the understanding of PDGF/SNAI1-activated CAFs in matrix remodeling and angiogenesis stimulation.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer

  • López de Maturana, Evangelina
  • Rodríguez, Juan Antonio
  • Alonso, Lola|||0000-0002-3493-718X
  • Lao, Oscar
  • Molina Montes, Esther|||0000-0002-0428-2426
  • Martín-Antoniano, Isabel Adoración
  • Gómez-Rubio, Paulina
  • Lawlor, Rita
  • Carrato, Alfredo|||0000-0001-7749-8140
  • Hidalgo, Manuel|||0000-0002-3765-3318
  • Iglesias, Mar|||0000-0002-2274-4671
  • Molero, Xavier|||0000-0003-2473-7405
  • Löhr, Matthias
  • Michalski, Christopher
  • Perea, José
  • O'Rorke, Michael
  • Barberà, Victor Manuel
  • Tardón, Adonina|||0000-0001-5150-1209
  • Farré, Antoni|||0000-0003-1279-8868
  • Muñoz-Bellvis, Luis|||0000-0002-7809-5201
  • Crnogorac-Jurcevic, Tanja
  • Domínguez-Muñoz, Enrique
  • Gress, Thomas
  • Greenhalf, William
  • Sharp, Linda
  • Arnes, Luís
  • Cecchini, Lluís|||0000-0002-8873-0969
  • Balsells Valls, Joaquim|||0000-0002-1202-4136
  • Costello, Eithne
  • Ilzarbe, Lucas|||0000-0003-1798-6876
  • Kleeff, Jörg
  • Kong, Bo
  • Márquez, Mirari
  • Mora Brugués, Josefina|||0000-0001-6777-5132
  • O'Driscoll, Damian
  • Scarpa, Aldo
  • Ye, Weimin
  • Yu, Jingru
  • García-Closas, Montserrat
  • Kogevinas, Manolis|||0000-0002-9605-0461
  • Rothman, Nathaniel
  • Silverman, Debra T.
  • Albanes, Demetrius
  • Arslan, Alan A.
  • Beane-Freeman, Laura
  • Bracci, Paige M.
  • Brennan, Paul
  • Bueno-de-Mesquita, Bas
  • Buring, Julie
  • Canzian, Federico|||0000-0002-4261-4583
  • Du, Margaret
  • Gallinger, Steven
  • Gaziano, J. Michael
  • Goodman, Phyllis J.
  • Gunter, Marc
  • LeMarchand, Loic
  • Li, Donghui
  • Neale, Rachael E.
  • Peters, Ulrike
  • Petersen, Gloria M.
  • Risch, Harvey A.
  • Sánchez Pérez, María José|||0000-0003-4817-0757
  • Shu, Xiao-Ou
  • Thornquist, Mark D.
  • Visvanathan, Kala
  • Zheng, Wei|||0000-0003-1226-070X
  • Chanock, Stephen|||0000-0002-2324-3393
  • Easton, Douglas F.|||0000-0003-2444-3247
  • Wolpin, Brian M.
  • Stolzenberg-Solomon, Rachael Z.
  • Klein, Alison P.
  • Amundadottir, Laufey T.|||0000-0003-1859-8971
  • Marti-Renom, Marc A.|||0000-0002-0151-4279
  • Real, Francisco X.|||0000-0001-9501-498X
  • Malats, Núria|||0000-0003-2538-3784
Pancreatic cancer (PC) is a complex disease in which both non-genetic and genetic factors interplay. To date, 40 GWAS hits have been associated with PC risk in individuals of European descent, explaining 4.1% of the phenotypic variance. We complemented a new conventional PC GWAS (1D) with genome spatial autocorrelation analysis (2D) permitting to prioritize low frequency variants not detected by GWAS. These were further expanded via Hi-C map (3D) interactions to gain additional insight into the inherited basis of PC. In silico functional analysis of public genomic information allowed prioritization of potentially relevant candidate variants. We identified several new variants located in genes for which there is experimental evidence of their implication in the biology and function of pancreatic acinar cells. Among them is a novel independent variant in NR5A2 (rs3790840) with a meta-analysis p value = 5.91E-06 in 1D approach and a Local Moran's Index (LMI) = 7.76 in 2D approach. We also identified a multi-hit region in CASC8 -a lncRNA associated with pancreatic carcinogenesis-with a lowest p value = 6.91E-05. Importantly, two new PC loci were identified both by 2D and 3D approaches: SIAH3 (LMI = 18.24), CTRB2/BCAR1 (LMI = 6.03), in addition to a chromatin interacting region in XBP1 -a major regulator of the ER stress and unfolded protein responses in acinar cells-identified by 3D; all of them with a strong in silico functional support. This multi-step strategy, combined with an in-depth in silico functional analysis, offers a comprehensive approach to advance the study of PC genetic susceptibility and could be applied to other diseases. The online version contains supplementary material available at 10.1186/s13073-020-00816-4.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A comprehensive analysis of candidate genes in familial pancreatic cancer families reveals a high frequency of potentially pathogenic germline variants

  • Earl, Julie
  • Galindo-Pumariño, Cristina
  • Encinas, Jessica
  • Barreto, Emma|||0000-0002-0410-2261
  • Castillo, Maria E.
  • Pachón, Vanessa
  • Ferreiro, Reyes
  • Rodríguez Garrote, Mercedes|||0000-0003-0486-6760
  • González-Martínez, Silvia
  • Ramon y Cajal, Teresa|||0000-0003-3490-3585
  • Diaz, Luis Robles
  • Chirivella-Gonzalez, Isabel
  • Rodriguez, Montse
  • Martínez de Castro, Eva|||0000-0002-5772-0741
  • García-Seisdedos, David
  • Muñoz, Gloria
  • Rosa, Juan Manuel Rosa
  • Marquez, Mirari
  • Malats, Núria|||0000-0003-2538-3784
  • Carrato, Alfredo|||0000-0001-7749-8140
The 5-year survival rate of patients with pancreatic ductal adenocarcinoma (PDAC) is around 5% due to the fact that the majority of patients present with advanced disease that is treatment resistant. Familial pancreatic cancer (FPC) is a rare disorder that is defined as a family with at least two affected first degree relatives, with an estimated incidence of 4%-10%. The genetic basis is unknown in the majority of families although around 10%-13% of families carry germline mutations in known genes associated with hereditary cancer and pancreatitis syndromes. Panel sequencing was performed of 35 genes associated with hereditary cancer in 43 PDAC cases from families with an apparent hereditary pancreatic cancer syndrome. Pathogenic variants were identified in 19% (5/26) of PDAC cases from pure FPC families in the genes MLH1, CDKN2A, POLQ and FANCM. Low frequency potentially pathogenic VUS were also identified in 35% (9/26) of PDAC cases from FPC families in the genes FANCC, MLH1, PMS2, CFTR, APC and MUTYH. Furthermore, an important proportion of PDAC cases harboured more than one pathogenic, likely pathogenic or potentially pathogenic VUS, highlighting the multigene phenotype of FPC. The genetic basis of familial or hereditary pancreatic cancer can be explained in 21% of families by previously described hereditary cancer genes. Low frequency variants in other DNA repair genes are also present in 35% of families which may contribute to the risk of pancreatic cancer development. This study was funded by the Instituto de Salud Carlos III (Plan Estatal de I + D + i 2013-2016): ISCIII (PI09/02221, PI12/01635, PI15/02101 and PI18/1034) and co-financed by the European Development Regional Fund ''A way to achieve Europe'' (ERDF), the Biomedical Research Network in Cancer: CIBERONC (CB16/12/00446), Red Temática de investigación cooperativa en cáncer: RTICC (RD12/0036/0073) and La Asociación Española contra el Cáncer: AECC (Grupos Coordinados Estables 2016).
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer

  • López de Maturana, Evangelina
  • Rodríguez, Juan Antonio
  • Lao, Oscar
  • Molina-Montes, Esther
  • Martín-Antoniano, Isabel Adoración
  • Molero Richard, Francesc Xavier
  • Balsells Valls, Joaquin
  • Alonso, Lola
Estructura genòmica 3D; Predisposició genètica; Risc de càncer de pàncrees, Estructura genómica 3D; Predisposición genética; Riesgo de cáncer de páncreas, 3D genomic structure; Genetic susceptibility; Pancreatic cancer risk, Background Pancreatic cancer (PC) is a complex disease in which both non-genetic and genetic factors interplay. To date, 40 GWAS hits have been associated with PC risk in individuals of European descent, explaining 4.1% of the phenotypic variance. Methods We complemented a new conventional PC GWAS (1D) with genome spatial autocorrelation analysis (2D) permitting to prioritize low frequency variants not detected by GWAS. These were further expanded via Hi-C map (3D) interactions to gain additional insight into the inherited basis of PC. In silico functional analysis of public genomic information allowed prioritization of potentially relevant candidate variants. Results We identified several new variants located in genes for which there is experimental evidence of their implication in the biology and function of pancreatic acinar cells. Among them is a novel independent variant in NR5A2 (rs3790840) with a meta-analysis p value = 5.91E−06 in 1D approach and a Local Moran’s Index (LMI) = 7.76 in 2D approach. We also identified a multi-hit region in CASC8—a lncRNA associated with pancreatic carcinogenesis—with a lowest p value = 6.91E−05. Importantly, two new PC loci were identified both by 2D and 3D approaches: SIAH3 (LMI = 18.24), CTRB2/BCAR1 (LMI = 6.03), in addition to a chromatin interacting region in XBP1—a major regulator of the ER stress and unfolded protein responses in acinar cells—identified by 3D; all of them with a strong in silico functional support. Conclusions This multi-step strategy, combined with an in-depth in silico functional analysis, offers a comprehensive approach to advance the study of PC genetic susceptibility and could be applied to other diseases., The work was partially supported by Fondo de Investigaciones Sanitarias (FIS), Instituto de Salud Carlos III, Spain (#PI061614, #PI11/01542, #PI0902102, #PI12/01635, #PI12/00815, #PI15/01573, #PI18/01347); Red Temática de Investigación Cooperativa en Cáncer, Spain (#RD12/0036/0034, #RD12/0036/0050, #RD12/0036/0073); Spanish Ministerio de Ciencia, Innovación y Universidades (#BFU2017-85926-P); Fundación Científica de la AECC, Spain; European Cooperation in Science and Technology - COST Action #BM1204: EUPancreas. EU-6FP Integrated Project (#018771-MOLDIAG-PACA), EU-FP7-HEALTH (#259737-CANCERALIA, #256974-EPC-TM-Net), EU-FP7-ERC (#609989); Associazione Italiana Ricerca sul Cancro (#12182); Cancer Focus Northern Ireland and Department for Employment and Learning; and ALF (#SLL20130022), Sweden; Pancreatic Cancer Collective (PCC): Lustgarten Foundation & Stand-Up to Cancer (SU2C #6179); Intramural Research Program of the Division of Cancer Epidemiology and Genetics, National Cancer Institute, USA; PANC4 GWAS RO1CA154823; NCI, US-NIH (#HHSN261200800001E).